Diagnostic performance of central vein sign for multiple sclerosis with a simplified three-lesion algorithm
暂无分享,去创建一个
Pascal Sati | Richard Watts | Daniel S Reich | Andrew J Solomon | Martina Absinta | Daniel Ontaneda | D. Reich | M. Absinta | R. Watts | D. Ontaneda | A. Solomon | P. Sati
[1] D. Reich,et al. Clinical 3-tesla FLAIR* MRI improves diagnostic accuracy in multiple sclerosis , 2016, Multiple sclerosis.
[2] M. Freedman,et al. MS, MRI, and the 2010 McDonald criteria , 2012, Neurology.
[3] P. Morgan,et al. Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions , 2016, Multiple sclerosis.
[4] Roland G. Henry,et al. The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative , 2016, Nature Reviews Neurology.
[5] J. Simon,et al. Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients , 2013, Multiple sclerosis.
[6] Gregory F. Wu,et al. The contemporary spectrum of multiple sclerosis misdiagnosis , 2016, Neurology.
[7] Jeffrey A. Cohen,et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.
[8] B. Rasmussen,et al. Migraine prevalence. A review of population-based studies. , 1994, Neurology.
[9] Nikos Evangelou,et al. The Central Vein Sign in Multiple Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T , 2017, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[10] Jeffrey A. Cohen,et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach , 2008, Multiple sclerosis.
[11] Pascal Sati,et al. FLAIR*: a combined MR contrast technique for visualizing white matter lesions and parenchymal veins. , 2012, Radiology.
[12] Nikos Evangelou,et al. Central veins in brain lesions visualized with high-field magnetic resonance imaging: a pathologically specific diagnostic biomarker for inflammatory demyelination in the brain. , 2013, JAMA neurology.
[13] D. Reich,et al. “Central vessel sign” on 3T FLAIR* MRI for the differentiation of multiple sclerosis from migraine , 2015, Annals of clinical and translational neurology.
[14] C. Poser,et al. Diagnostic criteria for multiple sclerosis , 2001, Clinical Neurology and Neurosurgery.
[15] Andrew J Solomon,et al. Misdiagnosis of Multiple Sclerosis: Frequency, Causes, Effects, and Prevention , 2013, Current Neurology and Neuroscience Reports.
[16] D. Reich,et al. Rapid, high-resolution, whole-brain, susceptibility-based MRI of multiple sclerosis , 2014, Multiple sclerosis.
[17] R. Lipton,et al. Migraine prevalence, disease burden, and the need for preventive therapy , 2007, Neurology.
[18] W. Valdar,et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study , 2006, The Lancet Neurology.
[19] Dennis Bourdette,et al. “Undiagnosing” multiple sclerosis , 2012, Neurology.